Related references
Note: Only part of the references are listed.Notch1 phenotype and clinical stage progression in non-small cell lung cancer
Dat Nguyen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
A Five-Gene Hedgehog Signature Developed as a Patient Preselection Tool for Hedgehog Inhibitor Therapy in Medulloblastoma
Yaping Shou et al.
CLINICAL CANCER RESEARCH (2015)
A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral gamma-Secretase Inhibitor PF-03084014
Wells A. Messersmith et al.
CLINICAL CANCER RESEARCH (2015)
Targeting Met and Notch in the Lfng-deficient, Met-amplified triple-negative breast cancer
Shubing Zhang et al.
CANCER BIOLOGY & THERAPY (2014)
Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Marcel Kool et al.
CANCER CELL (2014)
Organoid cultures for the analysis of cancer phenotypes
Norman Sachs et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Is It Better to Transfer Long-Term Cancer Survivors to General Practitioners or Develop Clinics for Long-Term Survivors Within the Cancer Centers?
Umberto Tirelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Discovery and Exploitation of Novel Targets by Approved Drugs
Luc Dirix
JOURNAL OF CLINICAL ONCOLOGY (2014)
Adaptive Dose-Finding Studies: A Review of Model-Guided Phase I Clinical Trials
Alexia Iasonos et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma
Daniel J. Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation
Hiba Ahmad Zahreddine et al.
NATURE (2014)
Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts
Aruna Kode et al.
NATURE (2014)
Tackling the cancer stem cells - what challenges do they pose?
Diwakar R. Pattabiraman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Can we safely target the WNT pathway?
Michael Kahn
NATURE REVIEWS DRUG DISCOVERY (2014)
Therapeutic modulation of Notch signalling - are we there yet?
Emma R. Andersson et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Prognostic Implications of Mutations in NOTCH1 and FBXW7 in Childhood T-ALL Treated According to the NOPHO ALL-1992 and ALL-2000 Protocols
Linda Fogelstrand et al.
PEDIATRIC BLOOD & CANCER (2014)
The Notch Pathway Is Important in Maintaining the Cancer Stem Cell Population in Pancreatic Cancer
Ethan V. Abel et al.
PLOS ONE (2014)
Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
Naoko Takebe et al.
PHARMACOLOGY & THERAPEUTICS (2014)
NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers
Hongfang Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A High Notch Pathway Activation Predicts Response to c Secretase Inhibitors in Proneural Subtype of Glioma Tumor-Initiating Cells
Norihiko Saito et al.
STEM CELLS (2014)
Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
Alexander Stoeck et al.
CANCER DISCOVERY (2014)
Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model
J. J. Arcaroli et al.
BRITISH JOURNAL OF CANCER (2013)
A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)
S. Sahebjam et al.
BRITISH JOURNAL OF CANCER (2013)
Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists
James Kim et al.
CANCER CELL (2013)
Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells
Ingrid Espinoza et al.
CANCER LETTERS (2013)
A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer
Jordan Berlin et al.
CLINICAL CANCER RESEARCH (2013)
Notch Pathway Activity Identifies Cells with Cancer Stem Cell-like Properties and Correlates with Worse Survival in Lung Adenocarcinoma
Khaled A. Hassan et al.
CLINICAL CANCER RESEARCH (2013)
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization
Virginia Tirino et al.
FASEB JOURNAL (2013)
Roles of PINK1, mTORC2, and mitochondria in preserving brain tumor-forming stem cells in a noncanonical Notch signaling pathway
Kyu-Sun Lee et al.
GENES & DEVELOPMENT (2013)
Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
Andy C. Rawstron et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemia
Justine E. Roderick et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Investigation of deregulated genes of Notch signaling pathway in human T cell acute lymphoblastic leukemia cell lines and clinical samples
Mahdi Paryan et al.
MOLECULAR BIOLOGY REPORTS (2013)
Noncanonical Regulation of the Hedgehog Mediator GLI1 by c-MYC in Burkitt Lymphoma
Joon Won Yoon et al.
MOLECULAR CANCER RESEARCH (2013)
Tumor-specific inhibition of jagged-dependent notch signaling using a Probody™ therapeutic.
Jason Sagert et al.
MOLECULAR CANCER THERAPEUTICS (2013)
A first-in-human Phase 1 study of anti-cancer stem cell (CSC) agent OMP-54F28 (FZD8-Fc) targeting the WNT pathway in patients with advanced solid tumors.
David C. Smith et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
Dereck Amakye et al.
NATURE MEDICINE (2013)
Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities
Mariella Gruber Filbin et al.
NATURE MEDICINE (2013)
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling
W. K. Chau et al.
ONCOGENE (2013)
Notch inhibitors for cancer treatment
Ingrid Espinoza et al.
PHARMACOLOGY & THERAPEUTICS (2013)
High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer
Julia Izrailit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models
Cathy C. Zhang et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Crosstalk between PKC alpha and Notch-4 in endocrine-resistant breast cancer cells
J. Yun et al.
ONCOGENESIS (2013)
What makes cancer stem cell markers different?
Uwe Karsten et al.
SPRINGERPLUS (2013)
Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
Josep Domingo-Domenech et al.
CANCER CELL (2012)
The Crosstalk of mTOR/S6K1 and Hedgehog Pathways
Yan Wang et al.
CANCER CELL (2012)
Mesenchymal Stromal Cell Mutations and Wound Healing Contribute to the Etiology of Desmoid Tumors
Adelaide M. Carothers et al.
CANCER RESEARCH (2012)
Genetics and functions of Kaposi's sarcoma-associated herpesvirus (KSHV) glycoproteins in virion egress, infectivity and tumorigenesis
Oswald D'Auvergne et al.
CANCER RESEARCH (2012)
A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice
Jo Waaler et al.
CANCER RESEARCH (2012)
Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway
Bhuvaneswari Ramaswamy et al.
CANCER RESEARCH (2012)
Jagged2 controls the generation of motor neuron and oligodendrocyte progenitors in the ventral spinal cord
M. A. Rabadan et al.
CELL DEATH AND DIFFERENTIATION (2012)
A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission
Stanley B. Kaye et al.
CLINICAL CANCER RESEARCH (2012)
A First-in-patient Phase I Study of the Novel Gamma Secretase Inhibitor PF-03084014 in Patients with Advanced Solid Tumor Malignancies
W. A. Messersmiths et al.
EUROPEAN JOURNAL OF CANCER (2012)
A phase II study of RO4929097 in metastatic colorectal cancer
Jonathan R. Strosberg et al.
EUROPEAN JOURNAL OF CANCER (2012)
Notch Activation by the Metalloproteinase ADAM17 Regulates Myeloproliferation and Atopic Barrier Immunity by Suppressing Epithelial Cytokine Synthesis
Aditya Murthy et al.
IMMUNITY (2012)
Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
Ian Krop et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
Anthony W. Tolcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Determining Mammosphere-Forming Potential: Application of the Limiting Dilution Analysis
Lauren M. Rota et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2012)
Defining the mode of tumour growth by clonal analysis
Gregory Driessens et al.
NATURE (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Aleksandar Sekulic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas
Arnout G. Schepers et al.
SCIENCE (2012)
Distinct Spatial and Molecular Features of Notch Pathway Assembly in Regulatory T Cells
Lakshmi R. Perumalsamy et al.
SCIENCE SIGNALING (2012)
Non-canonical Notch signaling: emerging role and mechanism
Peter Andersen et al.
TRENDS IN CELL BIOLOGY (2012)
Notch signals in the endothelium and cancer stem-like cells: opportunities for cancer therapy
Jian-Wei Gu et al.
VASCULAR CELL (2012)
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
David W. Ellison et al.
ACTA NEUROPATHOLOGICA (2011)
Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
K. Pandya et al.
BRITISH JOURNAL OF CANCER (2011)
Novel Synthetic Antagonists of Canonical Wnt Signaling Inhibit Colorectal Cancer Cell Growth
Jo Waaler et al.
CANCER RESEARCH (2011)
Modulation of Cancer and Stem Cell Biomarkers by the Notch Inhibitor MK-0752 Added to Endocrine Therapy for Early Stage ER plus Breast Cancer.
K. S. Albain et al.
CANCER RESEARCH (2011)
Pharmacokinetics of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors: the Role of Alpha-1-Acid Glycoprotein Binding
Richard A. Graham et al.
CLINICAL CANCER RESEARCH (2011)
Notch post-translationally regulates β-catenin protein in stem and progenitor cells
Chulan Kwon et al.
NATURE CELL BIOLOGY (2011)
Targeting cancer stem cells by inhibiting Wnt, notch, and Hedgehog pathways
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
A Pilot Phase II Study of Valproic Acid for Treatment of Low-Grade Neuroendocrine Carcinoma
Tabraiz A. Mohammed et al.
ONCOLOGIST (2011)
The Notch and TGF-β Signaling Pathways Contribute to the Aggressiveness of Clear Cell Renal Cell Carcinoma
Jonas Sjolund et al.
PLOS ONE (2011)
AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model
H Yao et al.
Blood Cancer Journal (2011)
Therapeutic promise and challenges of targeting DLL4/NOTCH1
Minhong Yan
VASCULAR CELL (2011)
Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition
Naoko Takebe et al.
BREAST CANCER RESEARCH (2011)
The Hedgehog's tale: developing strategies for targeting cancer
Jessica M. Y. Ng et al.
NATURE REVIEWS CANCER (2011)
Sonic Hedgehog Acts as a Negative Regulator of β-Catenin Signaling in the Adult Tongue Epithelium
Fabian T. Schneider et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
James Kim et al.
CANCER CELL (2010)
Combination of Notch Inhibitor MK-0752 and Endocrine Therapy for Early Stage ERα plus Breast Cancer in a Presurgical Window Pilot Study
K. S. Albain et al.
CANCER RESEARCH (2010)
Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
Hannah Harrison et al.
CANCER RESEARCH (2010)
Dishevelled: The hub of Wnt signaling
Chan Gao et al.
CELLULAR SIGNALLING (2010)
Targeting Hedgehog - a Cancer Stem Cell Pathway
Akil A. Merchant et al.
CLINICAL CANCER RESEARCH (2010)
The Difficulty of Targeting Cancer Stem Cell Niches
Mark A. LaBarge
CLINICAL CANCER RESEARCH (2010)
Loss of WNT-TCF addiction and enhancement of HH-GLI1 signalling define the metastatic transition of human colon carcinomas
Frederic Varnat et al.
EMBO MOLECULAR MEDICINE (2010)
Interactions between Hedgehog proteins and their binding partners come into view
Philip A. Beachy et al.
GENES & DEVELOPMENT (2010)
Alternative Promoter Usage at the Notch1 Locus Supports Ligand-Independent Signaling in T Cell Development and Leukemogenesis
Pablo Gomez-del Arco et al.
IMMUNITY (2010)
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Louis Vermeulen et al.
NATURE CELL BIOLOGY (2010)
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
Zainab Jagani et al.
NATURE MEDICINE (2010)
Notch-1 activates estrogen receptor-α-dependent transcription via IKKα in breast cancer cells
L. Hao et al.
ONCOGENE (2010)
Atopic Dermatitis-Like Disease and Associated Lethal Myeloproliferative Disorder Arise from Loss of Notch Signaling in the Murine Skin
Alexis Dumortier et al.
PLOS ONE (2010)
Notch-activated signaling cascade interacts with mitochondrial remodeling proteins to regulate cell survival
Lakshmi R. Perumalsamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
Jynho Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma
Silvia Buonamici et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Sulindac Inhibits Canonical Wnt Signaling by Blocking the PDZ Domain of the Protein Dishevelled
Ho-Jin Lee et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
A hierarchical cascade activated by non-canonical Notch signaling and the mTOR-Rictor complex regulates neglect-induced death in mammalian cells
L. R. Perumalsamy et al.
CELL DEATH AND DIFFERENTIATION (2009)
DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
Timothy Hoey et al.
CELL STEM CELL (2009)
Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled
David Grandy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A Wnt Survival Guide: From Flies to Human Disease
Andy J. Chien et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia
P. J. Real et al.
LEUKEMIA (2009)
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang et al.
NATURE (2009)
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma.
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
GSK3β is a negative regulator of the transcriptional coactivator MAML1
Mariana Saint Just Ribeiro et al.
NUCLEIC ACIDS RESEARCH (2009)
Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis
A. Raafat et al.
ONCOGENE (2009)
Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer
Veronica Rodilla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine
Silvia Fre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Robert L. Yauch et al.
SCIENCE (2009)
A stochastic model for cancer stem cell origin in metastatic colon cancer
Christine Odoux et al.
CANCER RESEARCH (2008)
Cross-talk between Notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches
Paola Rizzo et al.
CANCER RESEARCH (2008)
Cancer stem cells - old concepts, new insights
L. Vermeulen et al.
CELL DEATH AND DIFFERENTIATION (2008)
The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression
Elizabeth Vincan et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Antitumor Efficacy Testing in Rodents
Melinda G. Hollingshead
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling
Ilaria Malanchi et al.
NATURE (2008)
A paracrine requirement for hedgehog signalling in cancer
Robert L. Yauch et al.
NATURE (2008)
ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor
C. Osipo et al.
ONCOGENE (2008)
Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis
X. Li et al.
ONCOGENE (2008)
Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signalling
W. J. Ingram et al.
ONCOGENE (2008)
Induction of sonic hedgehog mediators by transforming growth factor-β:: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo
Sylviane Dennler et al.
CANCER RESEARCH (2007)
Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells
Zhenyu Ji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Mats Hellstroem et al.
NATURE (2007)
An antagonist of dishevelled protein-protein interaction suppresses β-catenin-dependent tumor cell growth
Naoaki Fujii et al.
CANCER RESEARCH (2007)
Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer
V. Fernandez-Majada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Networking of WNT, FGF, notch, BMP, and hedgehog signaling pathways during carcinogenesis
Masaru Katoh
STEM CELL REVIEWS (2007)
Diversity of LEF/TCF action in development and disease
L. Arce et al.
ONCOGENE (2006)
Monounsaturated fatty acid modification of Wnt protein: Its role in Wnt secretion
Ritsuko Takada et al.
DEVELOPMENTAL CELL (2006)
Mining the Wnt pathway for cancer therapeutics
Nick Barker et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch- dependent ubiquitination
Lucia Di Marcotullio et al.
NATURE CELL BIOLOGY (2006)
Suppressing Wnt signaling by the hedgehog pathway through sFRP-1
Jing He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Expression of Notch and Wnt pathway components and activation of Notch signaling in medulloblastomas from heterozygous patched mice
Gabriel D. Dakubo et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
Andrei V. Krivtsov et al.
NATURE (2006)
Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling
NA Riobó et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells
JH van Es et al.
NATURE (2005)
Differential roles for the coactivators CBP and p300 on TCF/β-catenin-mediated survivin gene expression
H Ma et al.
ONCOGENE (2005)
LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling:: Arrows point the way
X He et al.
DEVELOPMENT (2004)
Chronic treatment with the γ-secretase inhibitor LY-411,575 inhibits β-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation
GT Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signaling in T cells
H Sade et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Modulation of notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation
J Milano et al.
TOXICOLOGICAL SCIENCES (2004)
The Wnt signaling pathway in development and disease
CY Logan et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2004)
Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional γ-secretase inhibitor
GH Searfoss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Eradication of pathogenic β-catenin by Skp1/Cullin/F box ubiquitination machinery
YY Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Wise, a context-dependent activator and inhibitor of Wnt signalling
N Itasaki et al.
DEVELOPMENT (2003)
Phosphorylation by glycogen synthase kinase-3β down-regulates Notch activity, a link for Notch and Wnt pathways
L Espinosa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Wnt proteins are lipid-modified and can act as stem cell growth factors
K Willert et al.
NATURE (2003)
Glycogen synthase kinase-3β modulates notch signaling and stability
DR Foltz et al.
CURRENT BIOLOGY (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action
ML Smith et al.
EUROPEAN JOURNAL OF CANCER (2000)
Share Paper
